Detalhe da pesquisa
1.
Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy.
N Engl J Med
; 386(21): 1998-2010, 2022 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35613022
2.
Is Short-Course Antibiotic Therapy Suitable for Pseudomonas aeruginosa Bloodstream Infections in Onco-hematology Patients With Febrile Neutropenia? Results of a Multi-institutional Analysis.
Clin Infect Dis
; 78(3): 518-525, 2024 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37795577
3.
Validation and comparison of 5th edition World Health Organization classification (WHO 2022) and International Consensus Classification proposals for MDS-SFB31.
Br J Haematol
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38654443
4.
Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO study.
Br J Haematol
; 204(5): 2049-2056, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38343073
5.
BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation.
Blood
; 139(25): 3630-3646, 2022 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35421216
6.
Hematologic health services and practical characteristics: report of a nationwide survey among Chinese hematologists.
BMC Health Serv Res
; 24(1): 326, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38475797
7.
Ultrasound-Assisted Extraction of Paeonol from Moutan Cortex: Purification and Component Identification of Extract.
Molecules
; 29(3)2024 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38338367
8.
Impact of the International Consensus Classification of myelodysplastic syndromes.
Br J Haematol
; 201(3): 443-448, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36575970
9.
ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms.
Haematologica
; 108(5): 1359-1373, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36005555
10.
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study.
Am J Hematol
; 98(10): 1588-1597, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470365
11.
Acinetobacter spp. bloodstream infection in hematological patients: a 10-year single-center study.
BMC Infect Dis
; 23(1): 796, 2023 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37964192
12.
Patient-Reported Outcomes in Young Adults with Myeloproliferative Neoplasms.
Acta Haematol
; 146(4): 293-306, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36812897
13.
STIMULUS-MDS2 design and rationale: a phase III trial with the anti-TIM-3 sabatolimab (MBG453) + azacitidine in higher risk MDS and CMML-2.
Future Oncol
; 19(9): 631-642, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37083373
14.
A phase II trial to assess the efficacy and safety of ropeginterferon α-2b in Chinese patients with polycythemia vera.
Future Oncol
; 19(11): 753-761, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37129584
15.
Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae in hematological patients: assessment of risk factors for mortality and treatment options.
Ann Clin Microbiol Antimicrob
; 22(1): 41, 2023 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37202758
16.
Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot study.
Hematol Oncol
; 40(4): 787-795, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35609279
17.
Clinical characteristics and risk factors of Aeromonas bloodstream infections in patients with hematological diseases.
BMC Infect Dis
; 22(1): 303, 2022 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35351036
18.
Molecular and clinical features of myeloid neoplasms with somatic DDX41 mutations.
Br J Haematol
; 192(6): 1006-1010, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32307695
19.
Is race important in genomic classification of hematological neoplasms?
Hematol Oncol
; 39(5): 728-732, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34392561
20.
Evaluation of Reduced-Dose Decitabine and Azacitidine for Treating Myelodysplastic Syndromes: A Retrospective Study.
Med Sci Monit
; 27: e928454, 2021 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33514682